Trump transferred to hospital, put on experimental drug

Last Updated on 4 months by News Admin

President Trump is receiving an experimental “antibody cocktail” drug and was expected to be airlifted to Walter Reed National Medical Center on Friday afternoon after testing positive for COVID-19, according to White House aides and his personal doctor.

Press secretary Kayleigh said the visit was precautionary and that Trump, 74, will continue working out of the presidential suite at the premiere military hospital in Maryland.

“President Trump remains in good spirits, has mild symptoms, and has been working throughout the day,” McEnany said in a statement. “President Trump appreciates the outpouring of support.”

Trump’s travel to Walter Reed comes less than 24 hours after he revealed in the small hours Friday that both he and the first lady had tested positive for COVID-19.

Before the Walter Reed announcement, Dr. Sean Conley, Trump’s personal White House physician, said in a letter that the president is being administered an experimental “antibody cocktail” drug from pharmaceutical manufacturer Regeneron.

The drug is meant to reduce the time needed to ease symptoms from COVID-19 in patients in hopes of preventing the need for hospitalization, according to the manufacturer.

Conley wrote in the letter that Trump is “fatigued but in good spirits.” Because of his age, body weight and history of heart issues, Trump is at increased risk of developing severe complications from the potentially lethal virus.

Melania Trump “remains well with only a mild cough and headache,” according to Conley.

Recommended For You

About the Author: News Admin

NEWS784 was founded in November 2015. We welcome press releases, photos, news tips and story ideas. Contact: WhatsApp: 496 2450